Kenvue (KVUE) Financials

Kenvue logo
$19.31 0.00 (0.00%)
As of 11/6/2026
Annual Income Statements for Kenvue

Annual Income Statements for Kenvue

This table shows Kenvue's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 1/2/2022 1/1/2023 12/31/2023 12/29/2024 12/28/2025
Net Income / (Loss) Attributable to Common Shareholders
2,078 2,064 1,664 1,030 1,470
Consolidated Net Income / (Loss)
2,078 2,064 1,664 1,030 1,470
Net Income / (Loss) Continuing Operations
2,078 2,064 1,664 1,030 1,470
Total Pre-Tax Income
2,925 2,637 2,190 1,415 1,999
Total Operating Income
2,920 2,675 2,512 1,841 2,414
Total Gross Profit
8,419 8,285 8,643 8,959 8,792
Total Revenue
15,054 14,950 15,444 15,455 15,124
Operating Revenue
15,054 14,950 15,444 15,455 15,124
Total Cost of Revenue
6,635 6,665 6,801 6,496 6,332
Operating Cost of Revenue
6,635 6,665 6,801 6,496 6,332
Total Operating Expenses
5,499 5,610 6,131 7,118 6,378
Selling, General & Admin Expense
5,484 5,633 6,141 6,329 6,088
Other Operating Expenses / (Income)
15 -35 -10 26 -23
Impairment Charge
- 12 0.00 578 23
Restructuring Charge
- 0.00 0.00 185 290
Total Other Income / (Expense), net
5.00 -38 -322 -426 -415
Interest & Investment Income
- 0.00 -250 -378 -379
Other Income / (Expense), net
5.00 -38 -72 -48 -36
Income Tax Expense
847 573 526 385 529
Basic Earnings per Share
$1.21 $1.20 $0.90 $0.54 $0.77
Weighted Average Basic Shares Outstanding
1.72B 1.72B 1.85B 1.92B 1.92B
Diluted Earnings per Share
$1.21 $1.20 $0.90 $0.54 $0.76
Weighted Average Diluted Shares Outstanding
1.72B 1.72B 1.85B 1.92B 1.92B
Weighted Average Basic & Diluted Shares Outstanding
- - 1.91B 1.91B 1.92B
Cash Dividends to Common per Share
- - $0.40 $0.81 $0.83

Quarterly Income Statements for Kenvue

This table shows Kenvue's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/29/2024 12/29/2024 3/30/2025 6/29/2025 9/28/2025 12/28/2025 3/29/2026 6/28/2026 9/27/2026
Net Income / (Loss) Attributable to Common Shareholders
296 58 383 293 322 420 398 330 474 456 430
Consolidated Net Income / (Loss)
296 58 383 293 322 420 398 330 474 456 430
Net Income / (Loss) Continuing Operations
296 58 383 293 322 420 398 330 474 456 430
Total Pre-Tax Income
427 65 577 346 458 588 526 427 672 598 609
Total Operating Income
550 154 654 483 558 692 629 535 767 699 706
Total Gross Profit
2,242 2,365 2,282 2,070 2,168 2,261 2,226 2,137 2,302 2,301 2,314
Total Revenue
3,894 4,000 3,899 3,662 3,741 3,839 3,764 3,780 3,909 3,955 3,886
Operating Revenue
3,894 4,000 3,899 3,662 3,741 3,839 3,764 3,780 3,909 3,955 3,886
Total Cost of Revenue
1,652 1,635 1,617 1,592 1,573 1,578 1,538 1,643 1,607 1,654 1,572
Operating Cost of Revenue
1,652 1,635 1,617 1,592 1,573 1,578 1,538 1,643 1,607 1,654 1,572
Total Operating Expenses
1,692 2,211 1,628 1,587 1,610 1,569 1,597 1,602 1,535 1,602 1,608
Selling, General & Admin Expense
1,573 1,641 1,590 1,525 1,537 1,504 1,512 1,535 1,453 1,537 1,569
Other Operating Expenses / (Income)
10 12 7.00 -71 13 5.00 1.00 -42 11 6.00 6.00
Restructuring Charge
41 48 31 65 60 60 84 86 71 59 33
Total Other Income / (Expense), net
-123 -89 -77 -137 -100 -104 -103 -108 -95 -101 -97
Interest & Investment Income
-95 -92 -96 - -94 -94 -93 -98 -95 -90 -89
Other Income / (Expense), net
-28 3.00 19 -42 -6.00 -10 -10 -10 0.00 -11 -8.00
Income Tax Expense
131 7.00 194 53 136 168 128 97 198 142 179
Basic Earnings per Share
$0.15 $0.03 $0.20 $0.16 $0.17 $0.22 $0.21 $0.17 $0.25 $0.24 $0.22
Weighted Average Basic Shares Outstanding
1.92B 1.92B 1.92B 1.92B 1.91B 1.92B 1.92B 1.92B 1.92B 1.92B 1.92B
Diluted Earnings per Share
$0.15 $0.03 $0.20 $0.16 $0.17 $0.22 $0.21 $0.16 $0.25 $0.24 $0.22
Weighted Average Diluted Shares Outstanding
1.92B 1.92B 1.92B 1.92B 1.93B 1.93B 1.92B 1.92B 1.92B 1.92B 1.93B
Weighted Average Basic & Diluted Shares Outstanding
1.91B 1.92B 1.92B 1.91B 1.92B 1.92B 1.92B 1.92B 1.92B 1.92B 1.92B

Annual Cash Flow Statements for Kenvue

This table details how cash moves in and out of Kenvue's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 1/2/2022 1/1/2023 12/31/2023 12/29/2024 12/28/2025
Net Change in Cash & Equivalents
122 491 151 -312 -8.00
Net Cash From Operating Activities
334 2,525 3,168 1,769 2,197
Net Cash From Continuing Operating Activities
334 2,525 3,168 1,769 2,197
Net Income / (Loss) Continuing Operations
2,078 2,064 1,664 1,030 1,470
Consolidated Net Income / (Loss)
2,078 2,064 1,664 1,030 1,470
Depreciation Expense
731 644 627 622 557
Non-Cash Adjustments To Reconcile Net Income
136 162 194 973 226
Changes in Operating Assets and Liabilities, net
-2,611 -345 683 -856 -56
Net Cash From Investing Activities
-171 -390 -488 -425 -436
Net Cash From Continuing Investing Activities
-171 -390 -488 -425 -436
Purchase of Property, Plant & Equipment
-295 -375 -469 -434 -475
Sale and/or Maturity of Investments
0.00 0.00 8,941 0.00 0.00
Other Investing Activities, net
47 -15 -8,960 9.00 39
Net Cash From Financing Activities
0.00 -1,583 -2,527 -1,565 -1,837
Net Cash From Continuing Financing Activities
0.00 -1,583 -2,527 -1,565 -1,837
Repayment of Debt
-7.00 14 381 222 -805
Repurchase of Common Equity
- 0.00 -7.00 -235 -197
Payment of Dividends
0.00 0.00 -766 -1,552 -1,581
Issuance of Debt
0.00 0.00 7,686 0.00 746
Issuance of Common Equity
0.00 0.00 4,241 0.00 0.00
Other Financing Activities, net
7.00 -1,597 -14,062 0.00 0.00
Effect of Exchange Rate Changes
-41 -61 -2.00 -91 68
Cash Interest Paid
0.00 0.00 224 439 440
Cash Income Taxes Paid
363 316 699 810 595

Quarterly Cash Flow Statements for Kenvue

This table details how cash moves in and out of Kenvue's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/29/2024 12/29/2024 3/30/2025 6/29/2025 9/28/2025 12/28/2025 3/29/2026 6/28/2026 9/27/2026
Net Change in Cash & Equivalents
-227 -141 43 13 -13 13 69 -77 13 35 -71
Net Cash From Operating Activities
287 440 249 793 428 621 294 854 489 688 700
Net Cash From Continuing Operating Activities
287 440 249 793 428 621 294 854 489 688 700
Net Income / (Loss) Continuing Operations
296 58 383 293 322 420 398 330 474 456 430
Consolidated Net Income / (Loss)
296 58 383 293 322 420 398 330 474 456 430
Depreciation Expense
149 141 182 150 136 142 141 138 143 145 143
Non-Cash Adjustments To Reconcile Net Income
185 585 75 128 60 54 46 66 47 47 43
Changes in Operating Assets and Liabilities, net
-343 -344 -391 222 -90 5.00 -291 320 -175 40 84
Net Cash From Investing Activities
-152 -85 -56 -132 -167 -90 -104 -75 -167 -78 -79
Net Cash From Continuing Investing Activities
-152 -85 -56 -132 -167 -90 -104 -75 -167 -78 -79
Purchase of Property, Plant & Equipment
-153 -90 -59 -132 -179 -88 -98 -110 -139 -64 -80
Other Investing Activities, net
1.00 5.00 3.00 - 12 -2.00 -6.00 35 -28 -14 1.00
Net Cash From Financing Activities
-326 -490 -162 -587 -310 -548 -110 -869 -295 -587 -679
Net Cash From Continuing Financing Activities
-326 -490 -162 -587 -310 -548 -110 -869 -295 -587 -679
Repayment of Debt
-12 3.00 46 28 -723 56 333 -471 -767 681 -276
Payment of Dividends
-383 -383 -393 -393 -392 -393 -398 -398 -398 -398 -403
Effect of Exchange Rate Changes
-36 -6.00 12 -61 - - -11 13 - - -13

Annual Balance Sheets for Kenvue

This table presents Kenvue's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 1/1/2023 12/31/2023 12/29/2024 12/28/2025
Total Assets
27,316 27,851 25,601 27,076
Total Current Assets
5,877 6,138 5,525 5,697
Cash & Equivalents
1,231 1,382 1,070 1,062
Accounts Receivable
2,122 2,073 2,165 2,382
Inventories, net
2,226 1,851 1,591 1,666
Prepaid Expenses
175 567 494 432
Other Current Assets
123 265 205 155
Plant, Property, & Equipment, net
1,820 2,042 1,849 2,212
Total Noncurrent Assets
19,619 19,671 18,227 19,167
Goodwill
9,185 9,271 8,843 9,509
Intangible Assets
9,853 9,619 8,474 8,694
Noncurrent Deferred & Refundable Income Taxes
147 158 184 237
Other Noncurrent Operating Assets
434 623 726 727
Total Liabilities & Shareholders' Equity
27,316 27,851 25,601 27,076
Total Liabilities
7,346 16,640 15,933 16,311
Total Current Liabilities
3,926 5,481 5,739 5,945
Short-Term Debt
0.00 599 1,552 1,453
Accounts Payable
1,829 2,489 2,254 2,473
Accrued Expenses
1,768 2,251 1,859 1,914
Current Deferred & Payable Income Tax Liabilities
329 142 74 105
Total Noncurrent Liabilities
3,420 11,159 10,194 10,366
Long-Term Debt
0.00 7,687 7,055 7,071
Noncurrent Deferred & Payable Income Tax Liabilities
2,479 2,621 2,261 2,354
Noncurrent Employee Benefit Liabilities
214 360 342 340
Other Noncurrent Operating Liabilities
727 491 536 601
Commitments & Contingencies
0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
19,970 11,211 9,668 10,765
Total Preferred & Common Equity
19,970 11,211 9,668 10,765
Preferred Stock
0.00 0.00 0.00 0.00
Total Common Equity
19,970 11,211 9,668 10,765
Common Stock
0.00 16,166 16,149 16,367
Retained Earnings
0.00 429 -93 -204
Treasury Stock
0.00 -7.00 -242 -439
Accumulated Other Comprehensive Income / (Loss)
-5,455 -5,377 -6,146 -4,959

Quarterly Balance Sheets for Kenvue

This table presents Kenvue's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/29/2024 12/29/2024 3/30/2025 6/29/2025 9/28/2025 3/29/2026 6/28/2026 9/27/2026
Total Assets
27,851 27,283 26,443 26,925 25,601 26,257 27,132 27,248 26,854 26,735 26,671
Total Current Assets
6,138 6,097 5,881 5,941 5,525 5,710 5,854 6,032 5,795 5,899 5,939
Cash & Equivalents
1,382 1,155 1,014 1,057 1,070 1,057 1,070 1,139 1,075 1,110 1,039
Accounts Receivable
2,073 2,160 2,240 2,394 2,165 2,312 2,331 2,416 2,501 2,476 2,504
Inventories, net
1,851 1,884 1,849 1,820 1,591 1,680 1,776 1,794 1,674 1,722 1,815
Prepaid Expenses
567 645 557 460 494 505 525 531 410 450 410
Other Current Assets
265 253 221 210 205 156 152 152 135 141 171
Plant, Property, & Equipment, net
2,042 2,005 2,004 1,776 1,849 1,927 2,038 2,092 2,208 2,226 2,233
Total Noncurrent Assets
19,671 19,181 18,558 19,208 18,227 18,620 19,240 19,124 18,851 18,610 18,499
Goodwill
9,271 9,032 8,973 9,297 8,843 9,136 9,486 9,441 9,376 9,265 9,251
Intangible Assets
9,619 9,378 8,762 8,887 8,474 8,586 8,804 8,716 8,540 8,406 8,330
Noncurrent Deferred & Refundable Income Taxes
158 171 206 228 184 199 220 237 232 247 244
Other Noncurrent Operating Assets
623 600 617 796 726 699 730 730 703 692 674
Total Liabilities & Shareholders' Equity
27,851 27,283 26,443 26,925 25,601 26,257 27,132 27,248 26,854 26,735 26,671
Total Liabilities
16,640 16,662 16,265 16,281 15,933 16,204 16,402 16,614 16,246 16,182 16,509
Total Current Liabilities
5,481 6,166 5,937 5,946 5,739 6,666 5,988 6,156 5,896 5,867 6,216
Short-Term Debt
599 1,522 1,427 1,648 1,552 2,429 1,553 1,913 1,589 1,406 1,121
Accounts Payable
2,489 2,602 2,437 2,274 2,254 2,332 2,568 2,445 2,533 2,577 2,685
Accrued Expenses
2,251 1,878 1,977 1,861 1,859 1,751 1,778 1,695 1,678 1,809 2,292
Current Deferred & Payable Income Tax Liabilities
142 164 96 163 74 154 89 103 96 75 118
Total Noncurrent Liabilities
11,159 10,496 10,328 10,335 10,194 9,538 10,414 10,458 10,350 10,315 10,293
Long-Term Debt
7,687 7,033 7,051 7,053 7,055 6,309 7,057 7,060 7,072 7,074 7,085
Noncurrent Deferred & Payable Income Tax Liabilities
2,621 2,568 2,392 2,378 2,261 2,320 2,380 2,425 2,354 2,328 2,297
Noncurrent Employee Benefit Liabilities
360 354 350 362 342 350 371 373 345 341 341
Other Noncurrent Operating Liabilities
491 541 535 542 536 559 606 600 579 572 570
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
11,211 10,621 10,178 10,644 9,668 10,053 10,730 10,634 10,608 10,553 10,162
Total Preferred & Common Equity
11,211 10,621 10,178 10,644 9,668 10,053 10,730 10,634 10,608 10,553 10,162
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
11,211 10,621 10,183 10,644 9,668 10,053 10,730 10,634 10,608 10,553 10,162
Common Stock
16,166 16,052 16,094 16,117 16,149 16,220 16,307 16,339 16,381 16,416 16,456
Retained Earnings
429 342 17 7.00 -93 -163 -136 -136 -128 -70 -447
Treasury Stock
-7.00 -98 -93 -121 -242 -305 -369 -439 -439 -439 -439
Accumulated Other Comprehensive Income / (Loss)
-5,377 -5,675 -5,835 -5,359 -6,146 -5,699 -5,072 -5,130 -5,206 -5,354 -5,408

Annual Metrics And Ratios for Kenvue

This table displays calculated financial ratios and metrics derived from Kenvue's official financial filings.

Metric 2021 2022 2023 2024 2025
Period end date 1/2/2022 1/1/2023 12/31/2023 12/29/2024 12/28/2025
Growth Metrics
- - - - -
Revenue Growth
0.00% -0.69% 3.30% 0.07% -2.14%
EBITDA Growth
0.00% -10.26% -6.52% -21.26% 21.53%
EBIT Growth
0.00% -9.85% -7.47% -26.52% 32.63%
NOPAT Growth
0.00% 0.93% -8.84% -29.79% 32.47%
Net Income Growth
0.00% -0.67% -19.38% -38.10% 42.72%
EPS Growth
0.00% -0.83% -25.00% -40.00% 40.74%
Operating Cash Flow Growth
0.00% 655.99% 25.47% -44.16% 24.19%
Free Cash Flow Firm Growth
0.00% 0.00% 115.22% -11.16% -66.53%
Invested Capital Growth
0.00% 0.00% -3.33% -5.02% 5.94%
Revenue Q/Q Growth
0.00% 0.00% 0.00% -0.03% 0.79%
EBITDA Q/Q Growth
0.00% 0.00% 395.48% -1.47% 2.51%
EBIT Q/Q Growth
0.00% 0.00% 0.00% -0.66% 3.66%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% -1.21% 0.59%
Net Income Q/Q Growth
0.00% 0.00% 0.00% -3.20% 2.58%
EPS Q/Q Growth
0.00% 0.00% 0.00% -1.82% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 10.69% -8.15% 2.86%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 105.02% -52.47%
Invested Capital Q/Q Growth
0.00% 0.00% 0.48% -5.92% -1.31%
Profitability Metrics
- - - - -
Gross Margin
55.93% 55.42% 55.96% 57.97% 58.13%
EBITDA Margin
24.29% 21.95% 19.86% 15.63% 19.41%
Operating Margin
19.40% 17.89% 16.27% 11.91% 15.96%
EBIT Margin
19.43% 17.64% 15.80% 11.60% 15.72%
Profit (Net Income) Margin
13.80% 13.81% 10.77% 6.66% 9.72%
Tax Burden Percent
71.04% 78.27% 75.98% 72.79% 73.54%
Interest Burden Percent
100.00% 100.00% 89.75% 78.92% 84.06%
Effective Tax Rate
28.96% 21.73% 24.02% 27.21% 26.46%
Return on Invested Capital (ROIC)
0.00% 22.35% 10.36% 7.59% 10.02%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 27.18% 1.73% 3.29% 5.95%
Return on Net Nonoperating Assets (RNNOA)
0.00% -1.68% 0.32% 2.28% 4.37%
Return on Equity (ROE)
0.00% 20.67% 10.67% 9.87% 14.39%
Cash Return on Invested Capital (CROIC)
0.00% -177.65% 13.74% 12.74% 4.25%
Operating Return on Assets (OROA)
0.00% 9.65% 8.85% 6.71% 9.03%
Return on Assets (ROA)
0.00% 7.56% 6.03% 3.85% 5.58%
Return on Common Equity (ROCE)
0.00% 20.67% 10.67% 9.87% 14.39%
Return on Equity Simple (ROE_SIMPLE)
0.00% 10.34% 14.84% 10.65% 0.00%
Net Operating Profit after Tax (NOPAT)
2,074 2,094 1,909 1,340 1,775
NOPAT Margin
13.78% 14.01% 12.36% 8.67% 11.74%
Net Nonoperating Expense Percent (NNEP)
0.00% -4.83% 8.63% 4.29% 4.07%
Return On Investment Capital (ROIC_SIMPLE)
- 10.48% 9.79% 7.33% 9.20%
Cost of Revenue to Revenue
44.07% 44.58% 44.04% 42.03% 41.87%
SG&A Expenses to Revenue
36.43% 37.68% 39.76% 40.95% 40.25%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
36.53% 37.53% 39.70% 46.06% 42.17%
Earnings before Interest and Taxes (EBIT)
2,925 2,637 2,440 1,793 2,378
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
3,656 3,281 3,067 2,415 2,935
Valuation Ratios
- - - - -
Price to Book Value (P/BV)
0.00 0.19 3.50 4.23 3.02
Price to Tangible Book Value (P/TBV)
0.00 4.08 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.25 0.25 2.54 2.64 2.15
Price to Earnings (P/E)
1.83 1.84 23.59 39.68 22.15
Dividend Yield
0.00% 0.00% 0.98% 3.80% 4.85%
Earnings Yield
54.66% 54.29% 4.24% 2.52% 4.51%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.14 2.55 2.81 2.20
Enterprise Value to Revenue (EV/Rev)
0.00 0.17 2.99 3.13 2.65
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.78 15.05 20.05 13.64
Enterprise Value to EBIT (EV/EBIT)
0.00 0.97 18.92 27.00 16.83
Enterprise Value to NOPAT (EV/NOPAT)
0.00 1.23 24.19 36.13 22.55
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 1.02 14.57 27.37 18.22
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 18.23 21.52 53.14
Leverage & Solvency
- - - - -
Debt to Equity
0.00 0.00 0.74 0.89 0.79
Long-Term Debt to Equity
0.00 0.00 0.69 0.73 0.66
Financial Leverage
0.00 -0.06 0.18 0.69 0.73
Leverage Ratio
0.00 1.37 1.77 2.56 2.58
Compound Leverage Factor
0.00 1.37 1.59 2.02 2.17
Debt to Total Capital
0.00% 0.00% 42.50% 47.10% 44.19%
Short-Term Debt to Total Capital
0.00% 0.00% 3.07% 8.49% 7.53%
Long-Term Debt to Total Capital
0.00% 0.00% 39.43% 38.60% 36.66%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% 100.00% 57.50% 52.90% 55.81%
Debt to EBITDA
0.00 0.00 2.70 3.56 2.90
Net Debt to EBITDA
0.00 0.00 2.25 3.12 2.54
Long-Term Debt to EBITDA
0.00 0.00 2.51 2.92 2.41
Debt to NOPAT
0.00 0.00 4.34 6.42 4.80
Net Debt to NOPAT
0.00 0.00 3.62 5.62 4.20
Long-Term Debt to NOPAT
0.00 0.00 4.03 5.26 3.98
Altman Z-Score
0.00 1.26 2.31 2.36 2.02
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - -
Current Ratio
0.00 1.50 1.12 0.96 0.96
Quick Ratio
0.00 0.85 0.63 0.56 0.58
Cash Flow Metrics
- - - - -
Free Cash Flow to Firm (FCFF)
0.00 -16,645 2,533 2,250 753
Operating Cash Flow to CapEx
153.21% 673.33% 675.48% 407.60% 462.53%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - -
Asset Turnover
0.00 0.55 0.56 0.58 0.57
Accounts Receivable Turnover
0.00 7.05 7.36 7.29 6.65
Inventory Turnover
0.00 2.99 3.34 3.77 3.89
Fixed Asset Turnover
0.00 8.21 8.00 7.94 7.45
Accounts Payable Turnover
0.00 3.64 3.15 2.74 2.68
Days Sales Outstanding (DSO)
0.00 51.81 49.57 50.04 54.87
Days Inventory Outstanding (DIO)
0.00 121.90 109.40 96.70 93.87
Days Payable Outstanding (DPO)
0.00 100.16 115.87 133.25 136.24
Cash Conversion Cycle (CCC)
0.00 73.55 43.10 13.49 12.50
Capital & Investment Metrics
- - - - -
Invested Capital
0.00 18,739 18,115 17,205 18,227
Invested Capital Turnover
0.00 1.60 0.84 0.88 0.85
Increase / (Decrease) in Invested Capital
0.00 18,739 -624 -910 1,022
Enterprise Value (EV)
0.00 2,571 46,162 48,411 40,022
Market Capitalization
3,802 3,802 39,258 40,874 32,560
Book Value per Share
$0.00 $11.64 $5.85 $5.04 $5.62
Tangible Book Value per Share
$0.00 $0.54 ($4.01) ($3.99) ($3.88)
Total Capital
0.00 19,970 19,497 18,275 19,289
Total Debt
0.00 0.00 8,286 8,607 8,524
Total Long-Term Debt
0.00 0.00 7,687 7,055 7,071
Net Debt
0.00 -1,231 6,904 7,537 7,462
Capital Expenditures (CapEx)
218 375 469 434 475
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 720 -126 268 143
Debt-free Net Working Capital (DFNWC)
0.00 1,951 1,256 1,338 1,205
Net Working Capital (NWC)
0.00 1,951 657 -214 -248
Net Nonoperating Expense (NNE)
-3.55 30 245 310 305
Net Nonoperating Obligations (NNO)
0.00 -1,231 6,904 7,537 7,462
Total Depreciation and Amortization (D&A)
731 644 627 622 557
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 4.82% -0.82% 1.73% 0.95%
Debt-free Net Working Capital to Revenue
0.00% 13.05% 8.13% 8.66% 7.97%
Net Working Capital to Revenue
0.00% 13.05% 4.25% -1.38% -1.64%
Earnings Adjustments
- - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.90 $0.54 $0.77
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 1.85B 1.92B 1.92B
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.90 $0.54 $0.76
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 1.85B 1.92B 1.92B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 1.91B 1.91B 1.92B
Normalized Net Operating Profit after Tax (NOPAT)
2,074 2,103 1,909 1,895 2,005
Normalized NOPAT Margin
13.78% 14.07% 12.36% 12.26% 13.26%
Pre Tax Income Margin
19.43% 17.64% 14.18% 9.16% 13.22%
Debt Service Ratios
- - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - -
Dividend Payout Ratio
0.00% 0.00% 46.03% 150.68% 107.55%
Augmented Payout Ratio
0.00% 0.00% 46.45% 173.50% 120.95%

Quarterly Metrics And Ratios for Kenvue

This table displays calculated financial ratios and metrics derived from Kenvue's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/29/2024 12/29/2024 3/30/2025 6/29/2025 9/28/2025 12/28/2025 3/29/2026 6/28/2026 9/27/2026
DEI Shares Outstanding
- - - - - - - - 1,916,732,090.00 1,920,008,668.00 1,920,773,467.00
DEI Adjusted Shares Outstanding
- - - - - - - - 1,916,732,090.00 1,920,008,668.00 1,920,773,467.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 0.25 0.24 0.22
Growth Metrics
- - - - - - - - - - -
Revenue Growth
1.09% -0.27% -0.41% -0.11% -3.93% -4.03% -3.46% 3.22% 4.49% 3.02% 3.24%
EBITDA Growth
-11.94% -64.52% 2.03% -5.74% 2.53% 176.51% -11.11% 12.18% 32.27% 1.09% 10.66%
EBIT Growth
-14.43% -77.31% -1.75% -2.65% 5.75% 334.39% -8.02% 19.05% 38.95% 0.88% 12.76%
NOPAT Growth
-22.64% -70.91% -18.34% -2.93% 2.90% 259.70% 9.63% 1.09% 37.90% 7.84% 4.74%
Net Income Growth
-36.89% -86.51% -12.56% -10.40% 8.78% 624.14% 3.92% 12.63% 47.21% 8.57% 8.04%
EPS Growth
-44.44% -86.96% -13.04% -5.88% 13.33% 633.33% 5.00% 0.00% 47.06% 9.09% 4.76%
Operating Cash Flow Growth
-64.21% -40.70% -63.06% -16.53% 49.13% 41.14% 18.07% 7.69% 14.25% 10.79% 138.10%
Free Cash Flow Firm Growth
0.00% 0.00% 101.00% 26.18% 103.85% 99.24% 69.00% -146.14% -88.07% 758.13% 453.33%
Invested Capital Growth
0.00% 0.00% 1.44% -5.02% -1.59% 3.56% 0.98% 5.94% 2.59% -1.90% -6.17%
Revenue Q/Q Growth
6.22% 2.72% -2.53% -6.08% 2.16% 2.62% -1.95% 0.43% 3.41% 1.18% -1.74%
EBITDA Q/Q Growth
7.02% -55.59% 186.91% -30.88% 16.41% 19.77% -7.77% -12.76% 37.25% -8.46% 0.96%
EBIT Q/Q Growth
15.23% -69.92% 328.66% -34.47% 25.17% 23.55% -9.24% -15.19% 46.10% -10.30% 1.45%
NOPAT Q/Q Growth
-9.51% -63.96% 215.91% -5.78% -4.09% 26.00% -3.71% -13.13% 30.85% -1.48% -6.48%
Net Income Q/Q Growth
-9.48% -80.41% 560.34% -23.50% 9.90% 30.43% -5.24% -17.09% 43.64% -3.80% -5.70%
EPS Q/Q Growth
-11.76% -80.00% 566.67% -20.00% 6.25% 29.41% -4.55% -23.81% 56.25% -4.00% -8.33%
Operating Cash Flow Q/Q Growth
-69.79% 53.31% -43.41% 218.47% -46.03% 45.09% -52.66% 190.48% -42.74% 40.70% 1.74%
Free Cash Flow Firm Q/Q Growth
-1,787.46% 0.77% 101.00% 653.25% -48.50% -119.68% 321.32% -305.63% 113.31% 986.32% 86.07%
Invested Capital Q/Q Growth
-0.52% -2.10% 3.66% -5.92% 3.07% 3.02% 1.08% -1.31% -0.18% -1.49% -3.31%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
57.58% 59.13% 58.53% 56.53% 57.95% 58.90% 59.14% 56.53% 58.89% 58.18% 59.55%
EBITDA Margin
17.23% 7.45% 21.93% 16.14% 18.39% 21.46% 20.19% 17.54% 23.28% 21.06% 21.64%
Operating Margin
14.12% 3.85% 16.77% 13.19% 14.92% 18.03% 16.71% 14.15% 19.62% 17.67% 18.17%
EBIT Margin
13.41% 3.93% 17.26% 12.04% 14.76% 17.77% 16.45% 13.89% 19.62% 17.40% 17.96%
Profit (Net Income) Margin
7.60% 1.45% 9.82% 8.00% 8.61% 10.94% 10.57% 8.73% 12.13% 11.53% 11.07%
Tax Burden Percent
69.32% 89.23% 66.38% 84.68% 70.31% 71.43% 75.67% 77.28% 70.54% 76.25% 70.61%
Interest Burden Percent
81.80% 41.40% 85.74% 78.46% 82.97% 86.22% 84.98% 81.33% 87.61% 86.92% 87.25%
Effective Tax Rate
30.68% 10.77% 33.62% 15.32% 29.69% 28.57% 24.33% 22.72% 29.46% 23.75% 29.39%
Return on Invested Capital (ROIC)
16.83% 6.03% 9.48% 9.77% 8.98% 10.86% 10.32% 9.34% 11.78% 11.47% 11.13%
ROIC Less NNEP Spread (ROIC-NNEP)
14.52% 3.90% 8.79% 8.17% 8.04% 9.87% 9.32% 8.22% 10.90% 10.44% 10.22%
Return on Net Nonoperating Assets (RNNOA)
10.12% 2.86% 6.03% 5.65% 5.87% 7.08% 6.78% 6.04% 8.06% 7.32% 7.37%
Return on Equity (ROE)
26.95% 8.89% 15.51% 15.42% 14.84% 17.94% 17.10% 15.38% 19.84% 18.79% 18.50%
Cash Return on Invested Capital (CROIC)
-180.04% -183.42% 6.04% 12.74% 9.16% 6.08% 8.62% 4.25% 8.14% 12.76% 17.45%
Operating Return on Assets (OROA)
15.22% 4.59% 9.88% 6.96% 8.43% 10.04% 9.11% 7.98% 11.30% 9.95% 10.35%
Return on Assets (ROA)
8.63% 1.70% 5.62% 4.63% 4.92% 6.18% 5.86% 5.01% 6.98% 6.60% 6.37%
Return on Common Equity (ROCE)
26.95% 8.89% 15.51% 15.42% 14.84% 17.94% 17.10% 15.38% 19.84% 18.79% 18.50%
Return on Equity Simple (ROE_SIMPLE)
14.04% 10.99% 10.00% 0.00% 10.50% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
381 137 434 409 392 494 476 413 541 533 498
NOPAT Margin
9.79% 3.44% 11.13% 11.17% 10.49% 12.88% 12.64% 10.94% 13.84% 13.48% 12.83%
Net Nonoperating Expense Percent (NNEP)
2.30% 2.13% 0.69% 1.61% 0.93% 0.99% 1.01% 1.11% 0.88% 1.03% 0.91%
Return On Investment Capital (ROIC_SIMPLE)
- - - 2.24% 2.09% 2.56% 2.43% 2.14% 2.81% 2.80% 2.71%
Cost of Revenue to Revenue
42.42% 40.88% 41.47% 43.47% 42.05% 41.10% 40.86% 43.47% 41.11% 41.82% 40.45%
SG&A Expenses to Revenue
40.40% 41.03% 40.78% 41.64% 41.09% 39.18% 40.17% 40.61% 37.17% 38.86% 40.38%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
43.45% 55.28% 41.75% 43.34% 43.04% 40.87% 42.43% 42.38% 39.27% 40.51% 41.38%
Earnings before Interest and Taxes (EBIT)
522 157 673 441 552 682 619 525 767 688 698
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
671 298 855 591 688 824 760 663 910 833 841
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.79 3.39 4.19 4.23 4.51 3.74 2.96 3.02 3.17 3.48 3.36
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
2.60 2.23 2.88 2.64 2.96 2.65 2.10 2.15 2.20 2.38 2.20
Price to Earnings (P/E)
27.01 30.81 41.87 39.68 42.89 28.27 21.99 22.15 20.70 22.15 20.23
Dividend Yield
1.90% 3.33% 3.46% 3.80% 3.44% 3.93% 5.01% 4.85% 4.72% 4.34% 4.69%
Earnings Yield
3.70% 3.25% 2.39% 2.52% 2.33% 3.54% 4.55% 4.51% 4.83% 4.51% 4.94%
Enterprise Value to Invested Capital (EV/IC)
2.65 2.38 2.85 2.81 2.99 2.61 2.13 2.20 2.26 2.46 2.39
Enterprise Value to Revenue (EV/Rev)
3.08 2.71 3.38 3.13 3.46 3.15 2.62 2.65 2.69 2.86 2.66
Enterprise Value to EBITDA (EV/EBITDA)
16.02 17.23 21.29 20.05 21.78 16.10 13.74 13.64 13.04 13.93 12.74
Enterprise Value to EBIT (EV/EBIT)
20.27 23.08 28.91 27.00 29.06 20.28 17.15 16.83 15.88 16.97 15.44
Enterprise Value to NOPAT (EV/NOPAT)
26.50 28.68 38.47 36.13 39.23 27.71 22.30 22.55 21.41 22.48 20.85
Enterprise Value to Operating Cash Flow (EV/OCF)
17.97 17.84 27.10 27.37 27.74 22.78 18.42 18.22 18.23 18.97 15.14
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 47.55 21.52 32.36 43.65 24.83 53.14 28.15 19.10 13.24
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.81 0.83 0.82 0.89 0.87 0.80 0.84 0.79 0.82 0.80 0.81
Long-Term Debt to Equity
0.66 0.69 0.66 0.73 0.63 0.66 0.66 0.66 0.67 0.67 0.70
Financial Leverage
0.70 0.73 0.69 0.69 0.73 0.72 0.73 0.73 0.74 0.70 0.72
Leverage Ratio
2.57 2.60 2.51 2.56 2.59 2.56 2.55 2.58 2.57 2.53 2.59
Compound Leverage Factor
2.10 1.08 2.15 2.01 2.15 2.21 2.16 2.10 2.25 2.20 2.26
Debt to Total Capital
44.61% 45.44% 44.98% 47.10% 46.50% 44.52% 45.76% 44.19% 44.95% 44.55% 44.68%
Short-Term Debt to Total Capital
7.94% 7.65% 8.52% 8.49% 12.93% 8.03% 9.76% 7.53% 8.25% 7.39% 6.10%
Long-Term Debt to Total Capital
36.68% 37.79% 36.46% 38.60% 33.57% 36.49% 36.01% 36.66% 36.70% 37.17% 38.57%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
55.39% 54.58% 55.02% 52.90% 53.50% 55.48% 54.24% 55.81% 55.05% 55.45% 55.32%
Debt to EBITDA
2.87 3.48 3.55 3.56 3.59 2.91 3.13 2.90 2.74 2.68 2.53
Net Debt to EBITDA
2.49 3.07 3.12 3.12 3.16 2.55 2.74 2.54 2.40 2.33 2.21
Long-Term Debt to EBITDA
2.36 2.90 2.88 2.92 2.59 2.39 2.47 2.41 2.24 2.23 2.18
Debt to NOPAT
4.76 5.80 6.41 6.42 6.47 5.01 5.08 4.80 4.51 4.32 4.14
Net Debt to NOPAT
4.11 5.10 5.64 5.62 5.69 4.39 4.44 4.20 3.95 3.76 3.61
Long-Term Debt to NOPAT
3.91 4.82 5.20 5.26 4.67 4.11 4.00 3.98 3.68 3.61 3.57
Altman Z-Score
2.10 1.88 2.30 2.18 2.28 2.09 1.75 1.80 1.89 2.02 1.88
Noncontrolling Interest Sharing Ratio
0.00% -0.05% 0.00% 0.00% 0.00% -0.02% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.99 0.99 1.00 0.96 0.86 0.98 0.98 0.96 0.98 1.01 0.96
Quick Ratio
0.54 0.55 0.58 0.56 0.51 0.57 0.58 0.58 0.61 0.61 0.57
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-17,640 -17,505 175 1,319 679 -134 296 -609 81 880 1,637
Operating Cash Flow to CapEx
187.58% 488.89% 422.03% 600.76% 239.11% 705.68% 300.00% 776.36% 351.80% 1,075.00% 875.00%
Free Cash Flow to Firm to Interest Expense
-185.68 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
3.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
1.41 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.14 1.17 0.57 0.58 0.57 0.57 0.55 0.57 0.58 0.57 0.58
Accounts Receivable Turnover
0.00 0.00 6.87 7.29 6.84 6.62 6.24 6.65 6.35 6.41 6.31
Inventory Turnover
0.00 0.00 3.52 3.77 3.60 3.51 3.48 3.89 3.80 3.68 3.59
Fixed Asset Turnover
0.00 0.00 8.48 7.94 7.78 7.49 7.76 7.45 7.40 7.23 7.18
Accounts Payable Turnover
0.00 0.00 2.87 2.74 2.60 2.54 2.66 2.68 2.62 2.50 2.52
Days Sales Outstanding (DSO)
0.00 0.00 53.16 50.04 53.34 55.10 58.50 54.87 57.44 56.94 57.82
Days Inventory Outstanding (DIO)
0.00 0.00 103.59 96.70 101.36 104.02 105.01 93.87 96.15 99.10 101.71
Days Payable Outstanding (DPO)
0.00 0.00 127.36 133.25 140.32 143.62 137.11 136.24 139.47 145.76 144.57
Cash Conversion Cycle (CCC)
0.00 0.00 29.39 13.49 14.37 15.50 26.39 12.50 14.12 10.28 14.95
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
18,021 17,642 18,288 17,205 17,734 18,270 18,468 18,227 18,194 17,923 17,329
Invested Capital Turnover
1.72 1.75 0.85 0.88 0.86 0.84 0.82 0.85 0.85 0.85 0.87
Increase / (Decrease) in Invested Capital
18,021 17,642 259 -910 -287 628 180 1,022 460 -347 -1,139
Enterprise Value (EV)
47,666 41,941 52,191 48,411 52,977 47,628 39,345 40,022 41,167 44,100 41,357
Market Capitalization
40,266 34,477 44,547 40,874 45,296 40,088 31,511 32,560 33,581 36,730 34,190
Book Value per Share
$5.55 $5.32 $5.56 $5.04 $5.26 $5.59 $5.54 $5.62 $5.53 $5.50 $5.29
Tangible Book Value per Share
($4.07) ($3.94) ($3.94) ($3.99) ($4.01) ($3.94) ($3.92) ($3.88) ($3.81) ($3.71) ($3.86)
Total Capital
19,176 18,656 19,345 18,275 18,791 19,340 19,607 19,289 19,269 19,033 18,368
Total Debt
8,555 8,478 8,701 8,607 8,738 8,610 8,973 8,524 8,661 8,480 8,206
Total Long-Term Debt
7,033 7,051 7,053 7,055 6,309 7,057 7,060 7,071 7,072 7,074 7,085
Net Debt
7,400 7,464 7,644 7,537 7,681 7,540 7,834 7,462 7,586 7,370 7,167
Capital Expenditures (CapEx)
153 90 59 132 179 88 98 110 139 64 80
Debt-free, Cash-free Net Working Capital (DFCFNWC)
298 357 586 268 416 349 650 143 413 328 -195
Debt-free Net Working Capital (DFNWC)
1,453 1,371 1,643 1,338 1,473 1,419 1,789 1,205 1,488 1,438 844
Net Working Capital (NWC)
-69 -56 -5.00 -214 -956 -134 -124 -248 -101 32 -277
Net Nonoperating Expense (NNE)
85 79 51 116 70 74 78 83 67 77 68
Net Nonoperating Obligations (NNO)
7,400 7,464 7,644 7,537 7,681 7,540 7,834 7,462 7,586 7,370 7,167
Total Depreciation and Amortization (D&A)
149 141 182 150 136 142 141 138 143 145 143
Debt-free, Cash-free Net Working Capital to Revenue
1.92% 2.31% 3.79% 1.73% 2.72% 2.31% 4.33% 0.95% 2.70% 2.13% -1.26%
Debt-free Net Working Capital to Revenue
9.38% 8.86% 10.63% 8.66% 9.63% 9.37% 11.92% 7.97% 9.73% 9.33% 5.43%
Net Working Capital to Revenue
-0.45% -0.36% -0.03% -1.38% -6.25% -0.89% -0.83% -1.64% -0.66% 0.21% -1.78%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.15 $0.03 $0.20 $0.16 $0.17 $0.22 $0.21 $0.17 $0.25 $0.24 $0.22
Adjusted Weighted Average Basic Shares Outstanding
1.92B 1.92B 1.92B 1.92B 1.91B 1.92B 1.92B 1.92B 1.92B 1.92B 1.92B
Adjusted Diluted Earnings per Share
$0.15 $0.03 $0.20 $0.16 $0.17 $0.22 $0.21 $0.16 $0.25 $0.24 $0.22
Adjusted Weighted Average Diluted Shares Outstanding
1.92B 1.92B 1.92B 1.92B 1.93B 1.93B 1.92B 1.92B 1.92B 1.92B 1.93B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.91B 1.92B 1.92B 1.91B 1.92B 1.92B 1.92B 1.92B 1.92B 1.92B 1.92B
Normalized Net Operating Profit after Tax (NOPAT)
410 635 455 464 434 537 539 498 591 578 522
Normalized NOPAT Margin
10.52% 15.88% 11.66% 12.67% 11.61% 13.99% 14.33% 13.17% 15.12% 14.61% 13.43%
Pre Tax Income Margin
10.97% 1.63% 14.80% 9.45% 12.24% 15.32% 13.97% 11.30% 17.19% 15.12% 15.67%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
5.49 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
4.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
3.88 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
2.40 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
77.06% 136.91% 144.92% 150.68% 147.82% 110.79% 109.98% 107.55% 97.84% 96.02% 94.50%
Augmented Payout Ratio
77.06% 136.91% 144.92% 173.50% 167.42% 129.90% 132.17% 120.95% 106.10% 100.24% 94.50%

Financials Breakdown Chart

Key Financial Trends

Kenvue’s latest results show improving cash generation and modest revenue growth, although leverage and balance-sheet quality remain important risks for investors. In Q2 2026, revenue increased to $3.96 billion from $3.84 billion in Q2 2025 and $3.66 billion in Q4 2024. Net income rose to $456 million, up from $420 million a year earlier, while diluted EPS was $0.24. However, revenue remains below the $4.01 billion reported in Q2 2023, indicating a gradual rather than rapid growth profile.

Profitability has generally improved from the unusually weak Q2 2024 period, when a $510 million impairment charge reduced net income to $58 million. Q2 2026 gross profit was $2.30 billion, representing a gross margin of approximately 58.2%, while operating income was $699 million, or about 17.7% of revenue. Operating margins are healthy but slightly below Q2 2025, as selling, general and administrative expense increased to $1.54 billion and restructuring costs remained elevated at $59 million.

Cash flow was a strong point. Operating cash flow reached $688 million in Q2 2026, compared with $621 million in Q2 2025 and $294 million in Q3 2025. After $64 million of capital expenditures, estimated free cash flow was approximately $624 million. The improvement also reflected a positive $40 million contribution from operating assets and liabilities, a meaningful reversal from the $175 million working-capital drag recorded in Q1 2026.

  • Revenue growth has returned: Q2 2026 revenue increased approximately 3.0% year over year and was slightly higher than Q1 2026.
  • Net income is improving: Q2 2026 net income rose approximately 9% from Q2 2025, and quarterly earnings have recovered substantially from the impairment-affected Q2 2024 period.
  • Operating cash flow remains robust: Kenvue generated $688 million of operating cash flow in Q2 2026, its strongest quarter since Q4 2025.
  • Free cash flow comfortably covered the dividend: Estimated Q2 free cash flow of $624 million exceeded the $398 million dividend payment by roughly $226 million.
  • Working-capital performance improved: Operating assets and liabilities provided $40 million of cash in Q2, compared with a $175 million use of cash in Q1 2026.
  • Capital spending moderated: Q2 capital expenditures fell to $64 million from $139 million in Q1 2026 and $88 million in Q2 2025, supporting near-term free cash flow.
  • Dividend payments appear consistent: Quarterly dividends were approximately $398 million in Q1 and Q2 2026, following payments near $392 million to $398 million in the prior year.
  • Liquidity is adequate but narrow: Cash and equivalents increased to $1.11 billion, while current assets of $5.90 billion were only slightly above current liabilities of $5.87 billion.
  • Debt remains substantial: Short- and long-term debt totaled approximately $8.48 billion at the end of Q2 2026, or nearly 7.6 times reported cash.
  • Asset quality and equity risks remain: Goodwill and intangible assets totaled approximately $17.7 billion, or about two-thirds of total assets, while accumulated other comprehensive losses were $5.35 billion.

Kenvue’s financing activity reduced cash by $587 million in Q2 2026, despite strong operating cash flow. The company ended the quarter with a modest $35 million increase in cash, suggesting that dividends and debt-related activity continue to absorb much of the cash generated by operations. Investors should also note that the filing’s individual debt issuance and repayment line items use inconsistent signs, making the net financing figure more reliable than interpreting those lines separately.

Overall, the statements point to a stable consumer-health business with improving earnings and cash conversion. The key issues to monitor are whether revenue growth can accelerate, whether restructuring expenses decline, and whether Kenvue can reduce its sizable debt burden without compromising its dividend. The company’s strong brands and recurring cash generation are positives, but the relatively thin current-asset cushion and large goodwill and intangible balances leave limited room for operational or impairment setbacks.

11/18/26 06:22 PM ETAI Generated. May Contain Errors.

Kenvue Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Kenvue's financial year ends in December. Their financial year 2025 ended on December 28, 2025.

Kenvue's net income appears to be on a downward trend, with a most recent value of $1.47 billion in 2025, falling from $2.08 billion in 2021. The previous period was $1.03 billion in 2024. See Kenvue's forecast for analyst expectations on what's next for the company.

Kenvue's total operating income in 2025 was $2.41 billion, based on the following breakdown:
  • Total Gross Profit: $8.79 billion
  • Total Operating Expenses: $6.38 billion

Over the last 4 years, Kenvue's total revenue changed from $15.05 billion in 2021 to $15.12 billion in 2025, a change of 0.5%.

In the past 11 quarters, Kenvue's cash and equivalents has ranged from $1.01 billion in Q2 2024 to $1.38 billion in Q4 2023, and is currently $1.04 billion as of their latest financial filing in Q3 2026.

Kenvue had total debt of $8.52 billion at the end of 2025, a 1.0% decrease from 2024, and none in 2021.

Over the last 4 years, Kenvue's book value per share changed from 0.00 in 2021 to 5.62 in 2025, a change of 561.9%.



Financial statements for NYSE:KVUE last updated on 10/30/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners